Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 12496-12497 [2016-05265]
Download as PDF
<![CDATA[
12496
Federal Register / Vol. 81, No. 46 / Wednesday, March 9, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–05235 Filed 3–8–16; 8:45 am]
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2016–05266 Filed 3–8–16; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Lhorne on DSK5TPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DD 16–001, Centers for Autism
and Developmental Disabilities
Research and Epidemiology (CADDRE):
Study to Explore Early Development
(SEED) 3.
Time and Date: 10:00 a.m.–6:00 p.m.,
EDT, April 7, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DD16–001, Centers for Autism
and Developmental Disabilities
Research and Epidemiology (CADDRE):
Study to Explore Early Development
(SEED) 3’’.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
VerDate Sep<11>2014
15:08 Mar 08, 2016
Jkt 238001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), DP 16–002, Michigan Lupus
Epidemiology and Surveillance (MILES)
Program Longitudinal Cohort Study.
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, April 5, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–002, Michigan Lupus
Epidemiology and Surveillance (MILES)
Program Longitudinal Cohort Study’’.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–05267 Filed 3–8–16; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 2:00–4:00 p.m., EDT,
March 28, 2016.
Place: Teleconference.
Status: The meeting is open to the
public; the toll free dial in number is 1–
877–951–7311 with a pass code of
7972741.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: Topics to be
discussed during the teleconference
include administrative/budget issues,
current emerging infectious disease
outbreak responses, and reports from
recent program meetings.
The agenda and any supplemental
material will be available at
www.cdc.gov/oid/BSC/
meetingschedule.html after March 20.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
Road NE., Mailstop D10, Atlanta,
Georgia 30333, Telephone: (404) 639–
4461.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\09MRN1.SGM
09MRN1
12497
Federal Register / Vol. 81, No. 46 / Wednesday, March 9, 2016 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2016–05265 Filed 3–8–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 11:30 a.m.–1:00 p.m.
EDT, April 08, 2016.
Place: This meeting will be held by
teleconference.
Status: This meeting is open to the
public, limited only by the availability
of telephone ports. The public is
welcome to participate during the
public comment, which is tentatively
scheduled from 12:40 p.m. to 12:45 p.m.
To participate on the teleconference,
please dial (888) 233–0592 and enter
code 33288611.
Purpose: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategies and
future needs and challenges faced by
State, Tribal, Local and Territorial
health agencies, and will provide
guidance on opportunities for CDC.
Matters for Discussion: The STLT
Subcommittee members will discuss
progress on implementation of ACDadopted recommendations related to the
health departments of the future,
additional developments that may
expand these recommendations, and
how CDC can best support STLT health
departments.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
John Auerbach, MBA, Designated
Federal Officer, STLT Subcommittee,
ACD, CDC, 4770 Buford Highway, MS
E70, Atlanta, Georgia 30341, Telephone
(404) 498–0300, Email:
OSTLTSDirector@cdc.gov. Please
submit comments to OSTLTSDirector@
cdc.gov by April 1, 2016.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–05264 Filed 3–8–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Evaluation of Domestic Human
Trafficking Demonstration Projects.
OMB No.: New Collection.
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS) is proposing a 2-year
data collection as part of the
‘‘Evaluation of Domestic Human
Trafficking Demonstration Projects’’
study. This notice addresses the crosssite process evaluation to be conducted
with the FY 2015 domestic human
trafficking demonstration sites funded
by the Family and Youth Services
Bureau (FYSB).
The objective of the process
evaluation is to describe program
operations and implementation
experience, such as start-up efforts,
service provision to a wide array of
trafficking victims, collaboration
development, training, and
sustainability actions. Information from
the evaluation will assist federal, state,
and community policymakers and
funders in laying the groundwork for
the refinement of program models to
serve domestic victims of human
trafficking, as well as evaluation
strategies for future programs targeting
trafficking victims.
The evaluation of domestic human
trafficking demonstration projects will
document and describe each site’s
community and organizational capacity;
partnership composition and
functioning; comprehensive, victimcentered services; and survivor
characteristics, experiences, and
outcomes. Primary data for the
evaluation will be collected via
qualitative interviews, including key
informant interviews, case narrative
interviews, client interviews, bimonthly
telephone interviews, and cost modules
(i.e., structured interviews with project
directors to collect information on
costs). Data will be collected via two site
visits per year, during 2016 and 2017.
Case narrative interviews will include
follow up interviews. Interviews from
multiple perspectives will enhance the
government’s understanding of
strategies by which grantees can
identify, engage and serve diverse
populations of victims of severe forms
of human trafficking.
Respondents: Project directors and
case managers at the three FY 2015
FYSB funded demonstration projects;
staff (e.g., program managers and
directors) from partner organizations
that are working with the three FY 2015
FYSB-funded demonstration projects;
and clients who have received services
from the three FY 2015 FYSB-funded
demonstration projects.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Lhorne on DSK5TPTVN1PROD with NOTICES
Instrument
Project Director Interview .....................................................
Case Manger Interview ........................................................
Partner Interviews ................................................................
Case Narrative Interview .....................................................
Client Interview ....................................................................
Human Trafficking Evaluation Cost Module/Human Trafficking Evaluation Labor Module ......................................
Bi-monthly Project Director Calls .........................................
VerDate Sep<11>2014
17:12 Mar 08, 2016
Jkt 238001
PO 00000
Frm 00052
Annual
number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Annual
burden hours
6
30
30
30
30
1
1
1
1
1
2
1.25
1.25
1
1
6
19
19
15
15
6
6
Fmt 4703
3
15
15
15
15
3
3
1
1
1
6
3
18
Sfmt 4703
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 81, Number 46 (Wednesday, March 9, 2016)]
[Notices]
[Pages 12496-12497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05265]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 2:00-4:00 p.m., EDT, March 28, 2016.
Place: Teleconference.
Status: The meeting is open to the public; the toll free dial in
number is 1-877-951-7311 with a pass code of 7972741.
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director, CDC;
the Director, OID; and the Directors of the National Center for
Immunization and Respiratory Diseases, the National Center for Emerging
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas:
Strategies, goals, and priorities for programs; research within the
national centers; and overall strategic direction and focus of OID and
the national centers.
Matters for Discussion: Topics to be discussed during the
teleconference include administrative/budget issues, current emerging
infectious disease outbreak responses, and reports from recent program
meetings.
The agenda and any supplemental material will be available at
www.cdc.gov/oid/BSC/meetingschedule.html after March 20.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T.,
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop
D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and
[[Page 12497]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2016-05265 Filed 3-8-16; 8:45 am]
BILLING CODE 4163-18-P
